Tema Neuroscience and Mental Health ETF Rating $22.83 -0.85 (-3.59%) Closing price 12:13 PM EasternExtended Trading$22.83 0.00 (0.00%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Neuroscience and Mental Health ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MNTL Aggregate RatingModerate Buy 2.80Holdings in MNTL have an aggregate rating of Moderate Buy based on 581 analyst ratings issued in the past year covering 39 companies (91.7% of the portfolio).MNTL Aggregate Price Target$22.83High Prediction$22.83Average Prediction$22.83Low Prediction$22.83Holdings in MNTL have an aggregate price target of $22.83 and a range of $22.83 to $22.83 covering 39 companies (91.7% of the portfolio).MNTL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy13 Buy rating(s)Moderate Buy24 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Neuroscience and Mental Health ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 39 MNTL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings11.09%VRTXVertex Pharmaceuticals$484.82-1.6%3.8304 of 5 stars2.65$508.65 4.9%26Analyst ForecastPositive News8.05%REGNRegeneron Pharmaceuticals$634.23-0.5%4.8138 of 5 stars2.76$966.88 52.4%25Analyst ForecastShort Interest ↑Positive News5.16%ARGXargenx$591.87+0.5%3.2344 of 5 stars2.91$687.00 16.1%23Positive News4.75%ALNYAlnylam Pharmaceuticals$270.02+0.6%4.3266 of 5 stars2.77$316.25 17.1%26Analyst Forecast4.43%TEVATeva Pharmaceutical Industries$15.39+2.0%2.5092 of 5 stars2.86$23.43 52.3%7Short Interest ↑4.36%LLYEli Lilly and Company$825.42+0.4%4.8003 of 5 stars2.85$1,009.72 22.3%20Positive News4.24%CRNXCrinetics Pharmaceuticals$33.59-3.3%4.3697 of 5 stars2.92$73.00 117.3%13Gap DownHigh Trading Volume4.07%NBIXNeurocrine Biosciences$110.60-2.3%4.92 of 5 stars2.83$165.38 49.5%23Positive News3.35%BIIBBiogen$136.91-1.1%4.8726 of 5 stars2.43$213.33 55.8%30Positive News2.83%SYKStryker$372.73+2.5%4.7621 of 5 stars2.80$421.90 13.2%20Positive News2.78%AXSMAxsome Therapeutics$116.63-1.6%4.7486 of 5 stars3.00$167.64 43.7%15Short Interest ↓Gap Down2.58%IONSIonis Pharmaceuticals$30.16-3.2%4.2253 of 5 stars2.67$58.37 93.6%21Analyst ForecastGap Down2.57%MDTMedtronic$89.92+2.6%4.3429 of 5 stars2.44$96.07 6.8%16Ex-DividendPositive News2.49%CPRXCatalyst Pharmaceuticals$24.25-1.8%4.8187 of 5 stars3.13$32.29 33.1%82.22%JAZZJazz Pharmaceuticals$124.19+1.0%4.9079 of 5 stars2.93$187.71 51.1%14Positive News2.10%DNLIDenali Therapeutics$13.55-8.3%4.3776 of 5 stars2.94$37.20 174.5%18Positive NewsGap DownHigh Trading Volume2.01%XENEXenon Pharmaceuticals$33.55-2.1%2.4448 of 5 stars3.00$57.38 71.0%9Analyst UpgradeNews CoveragePositive News1.91%ALKSAlkermes$33.02-0.6%4.5978 of 5 stars2.69$39.38 19.3%13Positive News1.72%ACADACADIA Pharmaceuticals$16.61-2.7%4.132 of 5 stars2.50$23.93 44.1%16Gap Down1.67%PTCTPTC Therapeutics$50.96-6.0%3.8732 of 5 stars2.53$63.77 25.1%15Analyst ForecastGap DownHigh Trading Volume1.64%PENPenumbra$267.84+0.1%4.7153 of 5 stars2.88$294.47 9.9%17Positive News1.61%OPCHOption Care Health$34.95+0.6%3.9093 of 5 stars2.75$33.00 -5.6%8Positive News1.59%DXCMDexCom$68.29+0.8%4.8938 of 5 stars2.89$99.82 46.2%19Positive News1.57%RNAAvidity Biosciences$29.55-6.5%2.5329 of 5 stars3.00$66.69 125.7%13Positive NewsGap Down1.54%SRRKScholar Rock$32.15-2.1%4.076 of 5 stars3.00$42.67 32.7%6Positive NewsGap Down1.35%SRPTSarepta Therapeutics$63.81-9.4%4.8379 of 5 stars2.78$164.05 157.1%23Analyst DowngradeGap DownHigh Trading Volume1.09%IMVTImmunovant$17.09-7.0%2.6002 of 5 stars3.00$41.00 139.9%10High Trading Volume1.02%BHVNBiohaven$24.06-13.0%3.8592 of 5 stars3.07$62.77 160.9%15Gap DownHigh Trading Volume0.89%DAWNDay One Biopharmaceuticals$7.94-1.6%2.8968 of 5 stars3.13$32.29 306.6%8Gap Down0.77%PRTAProthena$12.42-5.5%3.2571 of 5 stars2.75$55.00 343.0%8Positive NewsGap Down0.73%TALKTalkspace$2.56-2.9%4.1084 of 5 stars3.00$4.38 71.2%6Short Interest ↓0.71%ACHCAcadia Healthcare$30.32+0.7%4.4116 of 5 stars2.63$52.19 72.1%8Earnings ReportUpcoming EarningsGap DownHigh Trading Volume0.63%NTLAIntellia Therapeutics$7.11-12.0%4.4392 of 5 stars2.63$37.56 428.6%19Analyst RevisionGap DownHigh Trading Volume0.55%DYNDyne Therapeutics$10.46-8.6%2.854 of 5 stars3.07$47.46 353.7%15Gap Down0.55%VYGRVoyager Therapeutics$3.38-7.4%4.6048 of 5 stars3.11$13.97 313.2%90.38%PRAXPraxis Precision Medicines$37.87-2.0%2.3245 of 5 stars2.78$123.33 225.7%9Positive NewsHigh Trading Volume0.38%SLDBSolid Biosciences$3.70-14.4%3.4579 of 5 stars3.33$15.67 323.4%12Positive NewsGap DownHigh Trading Volume0.18%ARVNArvinas$7.02-7.5%3.6178 of 5 stars2.67$35.50 405.7%15Short Interest ↓Gap DownHigh Trading Volume0.14%RAPPRapport Therapeutics$10.03-0.2%1.6874 of 5 stars3.00$35.00 249.0%3Short Interest ↑ This page (NASDAQ:MNTL) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredAI Boom Takes a Shocking Turn…AI is Creating Fortunes… (but not where you think!) Bryce Paul and the team at Crypto101 just released a br...Crypto 101 Media | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Neuroscience and Mental Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Neuroscience and Mental Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
